.avif)
SAN DIEGO & PARIS - Scientist.com, the life science industry’s leading online marketplace for outsourced research, and the Brain and SpineInstitute incubator, iPEPS-ICM, the first innovation accelerator dedicated to brain diseases in France, are partnering to launch a call for biotech startups developing novel approaches to fighting CNS diseases as part of a pitch competition.
This startup call is aimed at helping young biotechentrepreneurs to fast track the development of their innovative projects in oneof the most thriving research and innovation ecosystems in Europe. This competition is open to biotechstartups worldwide in existence for less than two years developing a noveltherapeutic and/or diagnostic approach with a main focus on central nervoussystem diseases (neuro-oncology, psychiatry, neurological disorders orpreventive health).
“In the field of disease of the nervous system; theprobability that drug candidates reach the market is only 7%, compared with anaverage of 15%,” stated Julien Elric, iPEPS incubator manager, “This outcomemakes it very difficult for young enterprises to establish in biotechnology.This startup competition is here to help young entrepreneurs to develop theirinnovation in the best environment.”
Applications can be submitted from May 28, 2018 through July 16, 2018. An expert panel of judges will narrow the applicant field to 12 in its initial round of selections in early September. A second round of selections occurring in mid-September will determine the winner and one runner up. The winner will have the opportunity to pitch the project to an audience of investors and experts at an event scheduled for late September.
The grand prize winner receives 6 months free rent atiPEPS’ state-of-the-art facilities located in Paris’ 13th district, includingconsulting with experts in preclinical/clinical development as well as $10K in research services providedthrough the Scientist.com marketplace. One runner-up willreceive 3 months free rent at iPEPS and $6K in research services through the Scientist.commarketplace.
“Neurologicaldisorders affect almost a billion people globally,” commented Dan Kagan, PhD,COO of Scientist.com. “This science-based competition highlights novel approaches tothese types of diseases and provides two early-stage companies the opportunityto take the next step in the development of their innovative ideas.”
About The Brain and Spine Institute
Located in the heart of the Pitié-SalpêtrièreUniversity Hospital Center, the first neurology hospital in France, The brainand spine institute (ICM) is a strong link between basic research and theclinical world. The Institute consists of over 700 researchers and clinicians,17 cutting-edge technological platforms and 1000m² office space intended forincubation of startups. The objective is to produce ambitious research bycombining scientific creativity and therapeutic purpose.
For furtherinformation, please contact:
Axelle de Chaillé
axelle.dechaille@icm-institute.org
+33 (0)1.57.27.47.02 / +33 (0)7.63.31.55.96
Mathilde Gratiot
mathilde.gratiot@icm-institute.org
+ 33(0)1.57.27.41.87
.webp)
Scientist.com
Scientist.comは、科学研究のアウトソーシングという複雑な業務のために構築された、世界最大かつ初のプラットフォームです。
私たちは、製薬・バイオテクノロジー企業が、創薬や前臨床研究から臨床開発、製造、メディカルアフェアーズ、そして商業化に至るまで、パイプラインのあらゆる段階を支えるプロバイダーとの関係を構築、管理、拡大できるよう支援しています。一元化されたプラットフォームを通じて、組織は6,000社以上のグローバルなプロバイダーネットワークにアクセスし、調達ワークフローの効率化、コンプライアンスの維持、サプライヤー関係の管理を実現するとともに、データに基づいた洞察を活用して、より迅速かつ的確な意思決定を行うことが可能です。
現在、Scientist.comは世界の製薬企業トップ30社のうち24社を含む130以上のライフサイエンス関連組織を支援しており、業務の複雑さを軽減し、開発期間を短縮し、イノベーションをより迅速に患者へ届けるためのサポートを行っています。私たちの使命は、2050年までに人類のあらゆる疾患を治癒可能にすることです。